Hosted on MSN29d
Advil-maker Haleon investing $54.2 million in its Richmond plantZoom in: Haleon's Richmond facility is the company's R&D Center of Excellence, specializing in formulation development, microbiology, product stability, packaging design, and consumer science ...
Haleon to invest $54 mln in US R&D centre to ... invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.
I initiate coverage on Haleon with a "hold" rating due to decent results and potential for ongoing growth, despite a slight revenue slip last year. Haleon's dividend grew 10% and is well-covered ...
Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five per cent. However, revenue declined by 0.6 per cent on a reported basis ...
In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...
Shares of HLN opened at $10.45 on Wednesday. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a 50-day moving average price of $9.66 and a two-hundred day moving ...
The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity Current share price of UK£3.91 suggests Haleon is potentially 25% undervalued Analyst price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results